Renal histopathological lesions after orthotopic liver transplantation (OLT).
about
Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysisChronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate.Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review.Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipientsHydroxyeyhyl starch: Controversies revisitedRisk factors for end-stage kidney disease after pediatric liver transplantation.Chronic progressive calcineurin nephrotoxicity: an overstated concept.Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.Long-term results of liver transplantation.Long-term outcome after liver transplantation.T-cell co-stimulatory blockade in transplantation: two steps forward one step back!Hydroxyethyl starch: a review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use.Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation.Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial CellsOutcomes of Pediatric Kidney Transplantation in Recipients of a Previous Non-Renal Solid Organ Transplant.Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trialsClinical usefulness of kidney biopsy in liver transplant recipients with renal impairmentDo patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus?Renal Outcomes in Patients With IgA Nephropathy Undergoing Liver Transplant: A Retrospective Cohort Study.Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.Colloid-induced kidney injury: experimental evidence may help to understand mechanisms.Medical epidemiology of patients surviving ten years after liver transplantation.Renal histological lesions and outcome in liver transplant recipients.Chronic renal outcome after living donor liver transplantation.Modifiable patient factors are associated with the late decline in renal function following liver transplantation.Hot-topic debate on kidney function: renal-sparing approaches are beneficial.
P2860
Q22306541-87954E15-7BAD-4C9C-848F-5839BCFE8002Q34160624-70319BA4-A4B8-449E-A374-72E2DCF12C09Q34386552-75B33551-CD02-4707-9963-794907436EE3Q34497165-7A5D02BF-13ED-47D9-BD21-D1773E3A1BC5Q34527810-7487822A-CFD0-4736-824B-8AA978BB1EC0Q35096234-C50AC615-2D33-495C-A324-2E772302E552Q35929301-B13768CB-F093-4BF6-9A2A-E21B6DCFDC33Q36585425-154E56F6-369B-4211-9C1D-380A454EC4DBQ36903039-951314BF-285D-49D6-9E7C-E84BED83AC9AQ37605371-786A13A5-1910-4F84-B232-A431490705CAQ37863928-A6FE196E-6870-43DD-8D7D-58F8C862F08DQ38002368-EE417ED7-D0C1-4131-AEC4-0E09B28C8273Q38148197-57B5C9FB-BEBE-4E8E-BEE4-7F9FDC4995A1Q38243449-4DDD5DA0-B76E-4873-8D4C-72B5A4F45480Q38682089-C073B933-E529-4B7A-BA1F-AD45F1A37D17Q38757060-A905361F-F523-4A0C-9443-35C905C90919Q38774503-CC5F78FC-F4AC-425C-A226-FA0D1C0C92F0Q38924664-1B51F53D-575C-4040-A679-7C15EC99B9B8Q39198777-E97EAA4C-D6DE-48F2-8E60-92FEFA302C87Q39996506-B55D43FE-1FB5-456C-BF2B-018F8EFABF3DQ40158833-E78F9219-A170-495F-B82E-1EF796665F2CQ41217295-8295FF98-C252-4C4F-AA2C-5087A2726764Q42125704-1A1DFF10-605B-481E-9580-CE0F75A1DF71Q42163339-6672578B-C9D9-456B-9B78-031E7EC424E9Q43587180-F11C90BC-AD71-4F6E-A6F0-89AA88EF2DEDQ44045354-C77712B9-F8F2-42E3-B30F-294311E8029FQ47200470-BF0BA3A4-7F10-411C-9148-4E159F7EDE83Q51332860-5A5E159B-C750-4C8F-8EDA-BE4389E73C5CQ51691293-9A40C290-B21B-46E0-B95F-4A5CE8EF628D
P2860
Renal histopathological lesions after orthotopic liver transplantation (OLT).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Renal histopathological lesions after orthotopic liver transplantation (OLT).
@en
Renal histopathological lesions after orthotopic liver transplantation
@nl
type
label
Renal histopathological lesions after orthotopic liver transplantation (OLT).
@en
Renal histopathological lesions after orthotopic liver transplantation
@nl
prefLabel
Renal histopathological lesions after orthotopic liver transplantation (OLT).
@en
Renal histopathological lesions after orthotopic liver transplantation
@nl
P2093
P2860
P1476
Renal histopathological lesions after orthotopic liver transplantation (OLT)
@en
P2093
Corinne Antoine
Dominique Nochy
Evangeline Pillebout
Filomena Conti
Yvon Calmus
P2860
P304
P356
10.1111/J.1600-6143.2005.00852.X
P407
P50
P577
2005-05-01T00:00:00Z